Skip to main content

Array Technologies Inc

Exchange: NASDAQSector: HealthcareIndustry: Biotechnology

Array Technologies Inc

Current Price

$8.73

+1.87%

GoodMoat Value

$38.15

337.0% undervalued
Profile
Valuation (TTM)
Market Cap$1.33B
P/E-10.43
EV
P/B
Shares Out152.85M
P/Sales1.11
Revenue$1.21B
EV/EBITDA57.08

Array Technologies Inc (ARRY) Quality Analysis

ARRY GoodMoat Verdict

Full signal breakdown coming soon. Use the X-Ray tool for a detailed analysis.

ARRY Profitability

Profitability trend analysis coming soon

ARRY Growth

Growth trend analysis coming soon

ARRY Financial Health

Financial health indicators coming soon

ARRY Quality & Fundamental Analysis

Array Technologies Inc (ARRY) is a Healthcare company in the Biotechnology industry, listed on NASDAQ. This quality analysis page evaluates Array Technologies Inc's financial health using the Piotroski F-Score methodology, profitability ratios, growth trajectory, and balance sheet strength.

Array Technologies Inc has a Piotroski F-Score of N/A out of 9, measuring profitability, leverage, and operating efficiency. The company operates with a profit margin of -5.56%. Return on assets (ROA) stands at -4.61%.

with a current ratio of 2.31. Operating margin is -2.24%.

GoodMoat's quality analysis uses AI-powered insights to evaluate whether Array Technologies Inc is a fundamentally sound investment. The GoodMoat Verdict synthesizes profitability, growth, and financial health scores into a clear investment quality rating. Use these metrics alongside valuation tools like the DCF calculator and fair value models to make informed investment decisions.